To The Moon

$Novo-Nordisk A/S(NVO)$ $Hims & Hers Health Inc.(HIMS)$ Earlier this year, when Novo Nordisk filed a lawsuit against telehealth platform Hims & Hers (HIMS), the market widely believed the latter’s good days were numbered. However, the plot took a dramatic 180-degree turn shortly after—Novo Nordisk not only dropped the lawsuit but also announced a partnership with Hims & Hers, agreeing to introduce its branded weight-loss drugs to the platform for sale at low prices. Fueled by this news, Hims & Hers’ stock surged 40% on Monday, marking one of its largest single-day gains in history. From Lawsuit to Partnership: A Turbulent Feud The relationship between Hims & Hers and Novo Nordisk has be

Oil prices are volatile, but oil & gas stocks are in focus! Institutions are bullish on XOM, LNG, BKR, BP, and GLNG for different themes—integrated giants, LNG exports, oilfield services, and more. Do you prefer the stability of Exxon or BP’s high dividend, or the growth potential of Cheniere or Golar? Are you adding oil & gas stocks to your portfolio amid geopolitical tensions? Share your picks and strategies below! As U.S.-Iran tensions escalate, international oil prices once breached the $100 mark, and the closure of the Strait of Hormuz has halted 20% of global crude oil shipments. The sharp volatility in the energy market has thrust the oil and gas sector back into the spotlight of the capital market. However, amid the complex oil and gas industry chain, how should investors c

Canada’s C$900M defense push is a win for Bombardier! With a transformed business, C$17.5B order backlog, and plans to hit C$10B revenue in 2026—do you think BBD.B is poised for long-term growth? Will defense orders and top-tier business jets drive further gains, or will currency fluctuations and global risks weigh it down? Share your thoughts on Bombardier’s investment potential below! The Government of Canada is stepping up efforts to strengthen its domestic defense industry. Industry Minister Melanie Joly announced in Ottawa on Monday that it will invest over C$900 million in defense innovation, with funds allocated to drone technology and a new $Bombardier Inc.(BDRAD)$ aircraft. This funding is part of the federal government’s defense industr

Gold prices crashed below $5,100, but global gold ETFs still raked in $5.3B in February—ninth straight month of inflows! Do you see this pullback as a buying opportunity amid geopolitical risks and central bank buying, or will the strong dollar keep pressuring prices? Are you adding gold to your portfolio now, or waiting for more clarity on interest rates? Share your take on the gold market’s next move below! International gold prices saw a sharp pullback this week. Pressured by a strong U.S. dollar and rising expectations of interest rate hikes, spot gold plummeted 3% at one point to around $5,015 per ounce, marking the largest single-day decline in nearly a month. Despite the volatile price swings—even a steep drop from recent highs—investors’ enthusiasm for gold allocation has only grow

Silver-focused juniors are making big moves! Silver North locks in 2-year drilling for Haldane (10k-14k meters) & Prismo updates Silver King drilling with silver minerals confirmed. Do you think these exploration projects will deliver significant resource upgrades? Are you bullish on SNAG and PRIZ as silver exploration heats up? Share your thoughts on these TSX-V/CSE silver plays below! Vancouver, British Columbia, March 9, 2026 – TheNewswire – Silver North Resources Ltd. $SILVER NORTH RESOURCES LTD.(TARSF)$ is pleased to announce the signing of a two-year drilling contract with Boart Longyear (“Boart”) for its fully funded 2026 and 2027 Haldane silver exploration program. Additionally, Silver North has entered into airborne geophysical surve

Looking for Alpha on the TSX? CCO, MDA, and EFX are crushing it in 2026—with gains up to 61%! Do you bet on Cameco’s nuclear renaissance tailwind, MDA’s space/defense dual growth, or Enerflex’s energy infrastructure + data center pivot? Are these stocks on your radar for excess returns, or are you sticking to index funds? Share your TSX Alpha-hunting strategy below! In 2026, the Toronto Stock Exchange (TSX) benchmark index has continued its steady upward trajectory, with the energy and basic materials sectors serving as key drivers. However, for investors seeking true Alpha (excess returns), merely tracking the index is far from sufficient—individual stocks that can significantly outperform the broader market are the accelerators of portfolio returns. This article focuses on three TSX star

Has the Magnificent Seven’s rally run out of steam in 2026? NVDA and META are sliding—and now trading at attractive forward P/E ratios! Do you see this as a buying opportunity for AI leaders, or are you worried about further declines? Are you team NVIDIA (AI infrastructure king) or team Meta (AI monetization master)? Share your take on whether these tech giants are worth adding to your portfolio now! The start of 2026 has brought an unexpected chill to the US stock market. The "Magnificent Seven"—the seven tech giants once revered by investors: NVIDIA, Alphabet, Apple, Microsoft, Amazon, Meta Platforms, and Tesla—have collectively lost momentum so far this year, with their stock prices trending downward. For long-term investors, short-term pullbacks of leading stocks often present a window

Dividend strategy is a winner for long-term investors! MSFT, XOM, JPM, AAPL, and JNJ are US stocks’ top dividend payers—returning over $70B combined annually! Do you prefer Microsoft’s growth + cash cow model, J&J’s 63-year dividend growth streak, or another pick? Are these dividend giants part of your portfolio, or are you hunting for higher-yield alternatives? Share your dividend investing thoughts below! On Wall Street, there are countless ways to make money, but when it comes to long-term, stable, and time-tested strategies, buying and holding high-quality dividend stocks ranks among the best. According to the report The Power of Dividends: Past, Present, and Future jointly released by Hartford Funds and Ned Davis Research, dividend-paying stocks delivered an annualized return of 9

Global chaos is driving gold to new highs! China’s central bank just notched 16 straight months of gold buying, and physical demand remains strong even above $5,000/oz. Do you think gold will keep surging amid geopolitical risks, or is a bigger pullback coming? Are you adding gold to your portfolio as a safe haven, or waiting for lower prices? Share your thoughts on the gold rally below! $Gold - main 2604(GCmain)$ As geopolitical tensions rage and the global economic outlook darkens, gold’s safe-haven allure shines brighter than ever. The People’s Bank of China has demonstrated strategic foresight through concrete actions—in February, it increased its gold reserves for the 16th consecutive month, extending the current gold-buying cycle to new

Could Iovance (IOVA) be the next 100x biotech stock? Its FDA-approved TIL therapy Amtagvi is making waves in melanoma, with NSCLC trials on the horizon! But will the complex production process and regulatory risks derail its potential? Are you willing to bet on this "miracle cancer drug" or steering clear of the high uncertainty? Share your thoughts on IOVA below! In the biotech sector, some stocks are labeled "penny stocks" due to extreme uncertainty—but it’s precisely this uncertainty that can harbor astonishing growth potential. $Iovance Biotherapeutics, Inc.(IOVA)$ is one such company: its flagship product Amtagvi, a customized cancer drug derived from patients’ own immune cells, features a complex and time-consuming production process yet has